Changes in hormonal and metabolic parameters in transgender subjects on cross-sex hormone therapy: a cohort study

R Vita, S Settineri, M Liotta, S Benvenga, F Trimarchi - Maturitas, 2018 - Elsevier
Objectives Gender identity disorder is defined as a strong and persistent cross-gender
identification that is associated with a remarkable uneasiness of living in an incongruent …

Effects of moderately increased testosterone concentration on physical performance in young women: a double blind, randomised, placebo controlled study

AL Hirschberg, JE Knutsson, T Helge… - British journal of sports …, 2020 - bjsm.bmj.com
Objective To investigate the effects of a moderate increase in serum testosterone on
physical performance in young, physically active, healthy women. Methods A double blind …

Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review

I Velho, TM Fighera, PK Ziegelmann, PM Spritzer - Andrology, 2017 - Wiley Online Library
Testosterone is the main hormonal agent used for cross‐sex hormone therapy in female‐to‐
male transgender persons. Our aim was to systematically review the literature concerning …

Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study

M Klaver, CJM De Blok, CM Wiepjes… - European Journal of …, 2018 - academic.oup.com
Objective Cross-sex hormonal therapy (CHT) in trans persons affects their total body fat and
total lean body mass. However, it is unknown how separate body regions are affected and …

Change in visceral fat and total body fat and the effect on cardiometabolic risk factors during transgender hormone therapy

M Klaver, D van Velzen, C de Blok… - The Journal of …, 2022 - academic.oup.com
Introduction Excess visceral fat increases the risk of type 2 diabetes and cardiovascular
disease and is influenced by sex hormones. Our aim was to investigate changes in visceral …

Impact of cross‐sex hormone therapy on bone mineral density and body composition in transwomen

TM Fighera, E da Silva, JDR Lindenau… - Clinical …, 2018 - Wiley Online Library
Objective Cross‐sex hormone therapy (CSHT) has been associated with changes in bone
and lean/fat mass. This study assessed bone mineral density (BMD), appendicular lean …

Metabolic effects of hormone therapy in transgender patients

JD Fernandez, LR Tannock - Endocrine Practice, 2016 - Elsevier
Objective: Transgender patients may seek hormone therapy to induce physical changes to
simulate their expressed or experienced gender. However, many providers are …

The levels and predictors of physical activity engagement within the treatment-seeking transgender population: a matched control study

BA Jones, E Haycraft… - Journal of Physical …, 2018 - journals.humankinetics.com
Background: Physical activity has been found to alleviate mental health problems and could
be beneficial for at-risk populations, such as transgender people. This study had 3 aims …

Breast development in transwomen after 1 year of cross-sex hormone therapy: results of a prospective multicenter study

CJM de Blok, M Klaver, CM Wiepjes… - The Journal of …, 2018 - academic.oup.com
Context Breast development is a key feature of feminization and therefore important to
transwomen (male-to-female transgender persons). It is not exactly known when breast …

Low bone mass is prevalent in male-to-female transsexual persons before the start of cross-sex hormonal therapy and gonadectomy

E Van Caenegem, Y Taes, K Wierckx, S Vandewalle… - Bone, 2013 - Elsevier
OBJECTIVE: Cross-sex hormonal therapy and sex reassignment surgery (including
gonadectomy) in transsexual persons has an impact on body composition and bone mass …